UnitedHealth shares plunge 33% as medical costs and adverse member mix dent profits
The US healthcare giant saw its stock fall sharply in 2025 as actual medical cost trends exceeded budget expectations by 2.5 percentage points, impacting earnings significantly.
UnitedHealth Group shares declined by 33 per cent in 2025, driven by medical cost trends that exceeded budget expectations by 2.5 percentage points and an influx of new members with worse health profiles than anticipated. The company, which oversees $400 billion in healthcare expense reimbursement, saw operating profits impacted by approximately $10 billion due to the cost deviation. The stock closed at approximately $393.85 per share on May 15, 2026, with a market capitalisation of about $357.67 billion.
Latitude Investment Management identified UnitedHealth Group as one of only two stocks in its portfolio to deliver a negative return for the year in its fourth-quarter 2025 investor letter. The firm attributed the decline to two primary factors: medical cost trends of plus 7.5 per cent against a plus 5 per cent budget, and the attraction of new members from weaker peers who exhibited worse health attributes.
UnitedHealth Group is the largest Managed Care Organisation in the United States, with a membership of 51 million people. It provides insurance and healthcare services through its UnitedHealthcare and Optum segments, overseeing government programmes including Medicare and Medicaid. In 2024, the company generated operating profits of $32 billion, representing an 8.3 per cent margin.
The deviation in costs had a substantial impact on the business. A minus 2.5 per cent deviation on costs on a total of $400 billion of spend resulted in a $10 billion impact on the business, which Latitude Investment Management noted as the main reason why the earnings shortfall this year was quite so dramatic. The firm also highlighted that the company attracted a large number of new members from weaker peers who exhibited worse health attributes than expected, likely due to UnitedHealth’s superior coverage and service.
UnitedHealth Group ranked 14th on a list of the 40 most popular stocks among hedge funds heading into 2026, with 145 hedge fund portfolios holding the stock at the end of the fourth quarter. The stock traded between $234.60 and $405.15 over the last 52 weeks, with a one-month return of 21.75 per cent. Latitude Investment Management emphasised a long-term, fundamentals-driven investment philosophy, noting that while stock prices can be volatile in the short run, they ultimately follow underlying earnings growth.
